Form 4 for ABT Abbott Laboratories
Accepted 2021-08-19 00:00:00 ET · period of report 2021-08-17 · accession 0001415889-21-004018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-19 | 2021-08-17 | ABT | Wainer Andrea F | EVP | M - OptEx | $41.07 | +14.5K | 64.3K | +29% | +$595.5K |
| D | 2021-08-19 | 2021-08-17 | ABT | Wainer Andrea F | EVP | S - Sale+OE | $125.00 | -14.5K | 49.8K | -23% | -$1.81M |
| DM | 2021-08-19 | 2021-08-17 | ABT | Wainer Andrea F | EVP | M - OptEx | $0.00 | -14.5K | 35.0K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-08-17 | M | A | 4,500 | $47.00 | 54,282 | D | — | — | |
| 2 | Common | Common shares without par value | 2021-08-17 | M | A | 10,000 | $38.40 | 64,282 | D | — | — | |
| 3 | Common | Common shares without par value | 2021-08-17 | S | D | 14,500 | $125.00 | 49,782 | D | — | — | |
| 4 | Derivative | Option (right to buy) | 2021-08-17 | M | D | 4,500 | $0.00 | 42,726 | D | $47.00 · 2016-02-20 to 2025-02-19 | 4,500 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| 5 | Derivative | Option (right to buy) | 2021-08-17 | M | D | 10,000 | $0.00 | 35,000 | D | $38.40 · 2017-02-19 to 2026-02-18 | 10,000 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |